\-\ Texto\\:\\ \ \(0\)\
\-\ physical\\ exam\\:\\	multiple\\ scattered\\ and\\ isolated\\ erythematous\\ papules\\,\\ papulovesicles\\,\\ necrotic\\ papules\\ and\\ crusted\\ plaques\\.\\ these\\ numbered\\ between\\ 12\\-15\\ lesions\\ and\\ were\\ distributed\\ on\\ the\\ arms\\,\\ thighs\\,\\ calves\\,\\ and\\ feet\\.\\ \ \(0\)\
\-\ laboratory\\:\\	wbc\\ \\=\\ 8\\.4\\;\\ esr\\ \\=\\ lmm\\;\\ rpr\\ \\=\\ nr\\;\\ chest\\ x\\-ray\\ \\=\\ normal\\ \ \(0\)\
\-\ histopathology\\:\\ band\\-like\\ dermal\\ infiltrate\\ invading\\ the\\ epidermis\\ with\\ epidermal\\ necrosis\\ and\\ vacuolopathy\\.\\ the\\ lymphocytes\\ are\\ atypical\\ with\\ pleomorphism\\ and\\ several\\ with\ \(0\)\
\-\ hyperchromatic\\ cerebriform\\ nuclei\\.\ \(1\)\
\-\ no\\ response\\ to\\ eight\\ weeks\\ of\\ tetracycline\\ and\\ topical\ \(0\)\
\-\ clobetasol\\.\\ intralesional\\ triamcinolone\\ does\\ seem\\ to\ \(0\)\
\-\ halt\\ progression\\ to\\ necrosis\\ and\\ scarring\\.\\ to\\ date\\ no\ \(0\)\
\-\ adenopathy\\ has\\ developed\\ and\\ the\\ patient\\ has\\ a\\ normal\\ chest\\ x\\-ray\\.\ \(0\)\
\-\ lymphomatoid\\ papulosis\\ \\(1997\\ uniformed\\ services\\ dermatology\\ seminar\\,\\ case\\#18b\\)\\ submitted\\ by\\:\\ lcdr\\ bradley\\ s\\.\\ graham\\,\\ mc\\,\\ usnr\ \(0\)\
\-\ presented\\ with\\ a\\ 2\\ week\\ history\\ of\\ crops\\ of\\ papules\\,\\ blisters\\,\\ and\\ ulcers\\.\\ starting\\ first\\ on\\ the\\ right\\ arm\\,\\ the\\ lesions\\ subsequently\\ spread\\ to\\ involve\\ his\\ abdomen\\ and\\ lower\\ legs\\.\\ other\\ than\\ pain\\ with\\ ulceration\\,\\ the\\ lesions\\ were\\ asymptomatic\\.\\ no\\ history\\ of\\ weight\\ loss\\,\\ fatigue\\ or\\ fever\\.\ \(0\)\
\-\ Keywords\\ by\\ value\\:\\ \ \(0\)\
\-\ \\=\\:\\ 0\\.08969570167360334\ \(0\)\
\-\ papules\\:\\ 0\\.08336132828917524\ \(0\)\
\-\ papulovesicles\\:\\ 0\\.04407759211983249\ \(0\)\
\-\ numbered\\:\\ 0\\.04407759211983249\ \(0\)\
\-\ calves\\:\\ 0\\.04407759211983249\ \(0\)\
\-\ lmm\\:\\ 0\\.04407759211983249\ \(0\)\
\-\ vacuolopathy\\:\\ 0\\.04407759211983249\ \(0\)\
\-\ cerebriform\\:\\ 0\\.04407759211983249\ \(0\)\
\-\ 18b\\:\\ 0\\.04407759211983249\ \(0\)\
\-\ papulosis\\:\\ 0\\.04061185621703277\ \(0\)\
\-\ crusted\\:\\ 0\\.038584530676491945\ \(0\)\
\-\ hyperchromatic\\:\\ 0\\.038584530676491945\ \(0\)\
\-\ clobetasol\\:\\ 0\\.038584530676491945\ \(0\)\
\-\ triamcinolone\\:\\ 0\\.038584530676491945\ \(0\)\
\-\ blisters\\:\\ 0\\.038584530676491945\ \(0\)\
\-\ x\\-ray\\:\\ 0\\.03852673793706591\ \(0\)\
\-\ 12\\-15\\:\\ 0\\.03714612031423304\ \(0\)\
\-\ pleomorphism\\:\\ 0\\.03714612031423304\ \(0\)\
\-\ tetracycline\\:\\ 0\\.03714612031423304\ \(0\)\
\-\ halt\\:\\ 0\\.03714612031423304\ \(0\)\
\-\ lymphomatoid\\:\\ 0\\.03714612031423304\ \(0\)\
\-\ bradley\\:\\ 0\\.03714612031423304\ \(0\)\
\-\ crops\\:\\ 0\\.03714612031423304\ \(0\)\
\-\ nr\\:\\ 0\\.03603040255766199\ \(0\)\
\-\ band\\-like\\:\\ 0\\.03603040255766199\ \(0\)\
\-\ graham\\:\\ 0\\.03603040255766199\ \(0\)\
\-\ lcdr\\:\\ 0\\.034348041374555924\ \(0\)\
\-\ usnr\\:\\ 0\\.034348041374555924\ \(0\)\
\-\ lesions\\:\\ 0\\.03431340759515921\ \(0\)\
\-\ necrosis\\:\\ 0\\.033731007134447044\ \(0\)\
\-\ rpr\\:\\ 0\\.03165305887089249\ \(0\)\
\-\ epidermis\\:\\ 0\\.03165305887089249\ \(0\)\
\-\ intralesional\\:\\ 0\\.03165305887089249\ \(0\)\
\-\ thighs\\:\\ 0\\.03125284533252481\ \(0\)\
\-\ 8\\.4\\:\\ 0\\.03125284533252481\ \(0\)\
\-\ seem\\:\\ 0\\.0308823054717562\ \(0\)\
\-\ \\;\\:\\ 0\\.030381317826788903\ \(0\)\
\-\ distributed\\:\\ 0\\.030214648508633583\ \(0\)\
\-\ epidermal\\:\\ 0\\.029355397224000292\ \(0\)\
\-\ topical\\:\\ 0\\.029098930752062536\ \(0\)\
\-\ dermal\\:\\ 0\\.028622379853040912\ \(0\)\
\-\ invading\\:\\ 0\\.028400121040186743\ \(0\)\
\-\ eight\\:\\ 0\\.027983212995491488\ \(0\)\
\-\ lymphocytes\\:\\ 0\\.027598407789810847\ \(0\)\
\-\ starting\\:\\ 0\\.02724111296990012\ \(0\)\
\-\ nuclei\\:\\ 0\\.02674891260583386\ \(0\)\
\-\ ulceration\\:\\ 0\\.026300851812385423\ \(0\)\
\-\ infiltrate\\:\\ 0\\.025389244028415647\ \(0\)\
\-\ submitted\\:\\ 0\\.02527159154136468\ \(0\)\
\-\ ulcers\\:\\ 0\\.025156643950241184\ \(0\)\
\-\ s\\.\\:\\ 0\\.025044279670980895\ \(0\)\
\-\ mc\\:\\ 0\\.025044279670980895\ \(0\)\
\-\ scarring\\:\\ 0\\.02493438513738702\ \(0\)\
\-\ erythematous\\:\\ 0\\.0248268541112822\ \(0\)\
\-\ 1997\\:\\ 0\\.023950833666156746\ \(0\)\
\-\ plaques\\:\\ 0\\.02386233578065974\ \(0\)\
\-\ arms\\:\\ 0\\.02386233578065974\ \(0\)\
\-\ histopathology\\:\\ 0\\.02386233578065974\ \(0\)\
\-\ seminar\\:\\ 0\\.023775377067100395\ \(0\)\
\-\ uniformed\\:\\ 0\\.023523222798965935\ \(0\)\
\-\ necrotic\\:\\ 0\\.02336191848787483\ \(0\)\
\-\ legs\\:\\ 0\\.023129318409700363\ \(0\)\
\-\ services\\:\\ 0\\.023054129022877665\ \(0\)\
\-\ dermatology\\:\\ 0\\.023054129022877665\ \(0\)\
\-\ fatigue\\:\\ 0\\.022835115909585695\ \(0\)\
\-\ \\:\\:\\ 0\\.0226054963198133\ \(0\)\
\-\ isolated\\:\\ 0\\.022230352857497384\ \(0\)\
\-\ feet\\:\\ 0\\.02186433583738091\ \(0\)\
\-\ esr\\:\\ 0\\.021634410271171793\ \(0\)\
\-\ date\\:\\ 0\\.02146864923458729\ \(0\)\
\-\ response\\:\\ 0\\.02141459465406621\ \(0\)\
\-\ progression\\:\\ 0\\.021255851162493313\ \(0\)\
\-\ spread\\:\\ 0\\.020666935984211394\ \(0\)\
\-\ chest\\:\\ 0\\.020447290000575186\ \(0\)\
\-\ involve\\:\\ 0\\.020140133405922262\ \(0\)\
\-\ scattered\\:\\ 0\\.0198961825850751\ \(0\)\
\-\ were\\:\\ 0\\.019402863366899212\ \(0\)\
\-\ subsequently\\:\\ 0\\.01936938000678597\ \(0\)\
\-\ adenopathy\\:\\ 0\\.01902441564935121\ \(0\)\
\-\ atypical\\:\\ 0\\.018517653178049775\ \(0\)\
\-\ arm\\:\\ 0\\.017895382305682744\ \(0\)\
\-\ \\,\\:\\ 0\\.01759615425862368\ \(0\)\
\-\ \\#\\:\\ 0\\.016758433094704442\ \(0\)\
\-\ developed\\:\\ 0\\.016450327424173572\ \(0\)\
\-\ has\\:\\ 0\\.01604699970494278\ \(0\)\
\-\ laboratory\\:\\ 0\\.01574545867927033\ \(0\)\
\-\ wbc\\:\\ 0\\.01557537425287906\ \(0\)\
\-\ weight\\:\\ 0\\.015314728925704327\ \(0\)\
\-\ does\\:\\ 0\\.014578105351920032\ \(0\)\
\-\ week\\:\\ 0\\.01451007709164114\ \(0\)\
\-\ fever\\:\\ 0\\.014456313132759831\ \(0\)\
\-\ asymptomatic\\:\\ 0\\.014442961989980437\ \(0\)\
\-\ first\\:\\ 0\\.014337417173929261\ \(0\)\
\-\ several\\:\\ 0\\.013735464178611939\ \(0\)\
\-\ between\\:\\ 0\\.01354247768112122\ \(0\)\
\-\ normal\\:\\ 0\\.013396124545991012\ \(0\)\
\-\ no\\:\\ 0\\.012906662260557028\ \(0\)\
\-\ abdomen\\:\\ 0\\.012656921314478483\ \(0\)\
\-\ loss\\:\\ 0\\.012402320862342197\ \(0\)\
\-\ his\\:\\ 0\\.01231444513823466\ \(0\)\
\-\ weeks\\:\\ 0\\.012126388784505742\ \(0\)\
\-\ history\\:\\ 0\\.011802145377070835\ \(0\)\
\-\ presented\\:\\ 0\\.011646788175112046\ \(0\)\
\-\ than\\:\\ 0\\.011195244274591369\ \(0\)\
\-\ these\\:\\ 0\\.0111192234597892\ \(0\)\
\-\ to\\:\\ 0\\.010676702711074657\ \(0\)\
\-\ physical\\:\\ 0\\.010482526347906192\ \(0\)\
\-\ and\\:\\ 0\\.009900495315272016\ \(0\)\
\-\ other\\:\\ 0\\.009848192743512243\ \(0\)\
\-\ lower\\:\\ 0\\.009609310346819314\ \(0\)\
\-\ exam\\:\\ 0\\.00938616969974769\ \(0\)\
\-\ case\\:\\ 0\\.009347522164336354\ \(0\)\
\-\ 2\\:\\ 0\\.009200522482552731\ \(0\)\
\-\ multiple\\:\\ 0\\.008999030017396345\ \(0\)\
\-\ on\\:\\ 0\\.007238910123654281\ \(0\)\
\-\ by\\:\\ 0\\.007114354516224374\ \(0\)\
\-\ are\\:\\ 0\\.005824369362648009\ \(0\)\
\-\ pain\\:\\ 0\\.005218040837653674\ \(0\)\
\-\ or\\:\\ 0\\.005007613744818538\ \(0\)\
\-\ the\\:\\ 0\\.0048387249646269035\ \(0\)\
\-\ right\\:\\ 0\\.0045081585455520835\ \(0\)\
\-\ patient\\:\\ 0\\.00428295965458194\ \(0\)\
\-\ a\\:\\ 0\\.003965998018186013\ \(0\)\
\-\ \\(\\:\\ 0\\.0036118086312193027\ \(0\)\
\-\ \\)\\:\\ 0\\.0035676884605665253\ \(0\)\
\-\ with\\:\\ 0\\.0029251044022472437\ \(0\)\
\-\ of\\:\\ 0\\.0023300760159597686\ \(0\)\
\-\ \\.\\:\\ 0\\.0019524744853540452\ \(0\)\
